U.S. Tissue Diagnostics Market Size & Outlook, 2025-2030
Related Markets
U.S. tissue diagnostics market highlights
- The U.S. tissue diagnostics market generated a revenue of USD 3,333.0 million in 2024 and is expected to reach USD 5,294.2 million by 2030.
- The U.S. market is expected to grow at a CAGR of 8.2% from 2025 to 2030.
- In terms of segment, immunohistochemistry was the largest revenue generating technology in 2024.
- Digital Pathology and Workflow is the most lucrative technology segment registering the fastest growth during the forecast period.
Tissue diagnostics market data book summary
| Market revenue in 2024 | USD 3,333.0 million |
| Market revenue in 2030 | USD 5,294.2 million |
| Growth rate | 8.2% (CAGR from 2025 to 2030) |
| Largest segment | Immunohistochemistry |
| Fastest growing segment | Digital Pathology and Workflow |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Immunohistochemistry, In situ Hybridization, Primary & Special Staining, Digital Pathology and Workflow, Anatomic Pathology, Molecular Pathology |
| Key market players worldwide | Roche Holding AG ADR, Abbott Laboratories, Thermo Fisher Scientific Inc, Siemens AG, Danaher Corp, BioMerieux SA, Qiagen NV, BD, Merck KGaA, GE Aerospace, Agilent Technologies Inc, Biogenex, Cell Signaling Technology, Bio SB, DiaGenic |
Other key industry trends
- In terms of revenue, U.S. accounted for 38.2% of the global tissue diagnostics market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. tissue diagnostics market is projected to lead the regional market in terms of revenue in 2030.
- Mexico is the fastest growing regional market in North America and is projected to reach USD 494.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Tissue Diagnostics Market Scope
Tissue Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| DiaGenic | View profile | 11-50 | Oslo, Oslo, Norway, Europe | http://www.diagenic.com/ |
| Cell Signaling Technology | View profile | 501-1000 | Danvers, Massachusetts, United States, North America | https://www.cellsignal.com |
| Bio SB | View profile | 11-50 | Goleta, California, United States, North America | https://www.biosb.com/ |
| Biogenex | View profile | 51-100 | Fremont, California, United States, North America | https://biogenex.com |
| BD | View profile | 10001+ | Franklin Lakes, New Jersey, United States, North America | https://www.bd.com |
| Qiagen NV | View profile | 5900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | https://www.qiagen.com |
| Agilent Technologies Inc | View profile | 17700 | 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 | https://www.agilent.com |
| Danaher Corp | View profile | 63000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | https://www.danaher.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| GE Aerospace | View profile | 125000 | One Financial Center, Suite 3700, Boston, MA, United States, 02111 | https://www.geaerospace.com |
| Siemens AG | View profile | 321000 | Werner-von-Siemens-Strabe 1, Munich, BY, Germany, 80333 | https://www.siemens.com |
| BioMerieux SA | View profile | 13982 | Marcy l’Etoile, Lyon, France, 69280 | http://www.biomerieux.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
| Roche Holding AG ADR | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
U.S. tissue diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to tissue diagnostics market will help companies and investors design strategic landscapes.
Immunohistochemistry was the largest segment with a revenue share of 27.73% in 2024. Horizon Databook has segmented the U.S. tissue diagnostics market based on immunohistochemistry, in situ hybridization, primary & special staining, digital pathology and workflow, anatomic pathology, molecular pathology covering the revenue growth of each sub-segment from 2018 to 2030.
According to National Cancer Institute, estimated new cancer cases in 2021 in the U.S. is 1.9 million. Ongoing strategic investments on cancer research have made the U.S. a global leader in the field. Recently, U.S. FDA approved Keytruda (pembrolizumab) for tumors with specific genetic changes, regardless of the type.
Keytruda has already been approved for lung cancer, Hodgkin lymphoma, and other cancer types. Cancer Prevention and Control Research Network is a flagship program by CDC for preventing cancer. Through colorectal cancer prevention and control initiatives, CDC is conducting and promoting initiatives for screening for colorectal cancer.
Molecular testing guidelines released by College of American Pathologist, the International Association for the Study of Lung Cancer, and Association of Molecular Pathology recommend that the test results be available within 2 weeks (10 working days) from the time the lab receives a specimen.
Reasons to subscribe to U.S. tissue diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. tissue diagnostics market databook
-
Our clientele includes a mix of tissue diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. tissue diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into U.S. tissue diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. tissue diagnostics market size, by technology, 2018-2030 (US$M)
U.S. Tissue Diagnostics Market Outlook Share, 2024 & 2030 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
